HERO TECHNOLOGIES (HENC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 45 sessions, September 4, 2025 to September 8, 2026
- Largest daily move
- +0% close of September 12, 2025
- 1-year change
- +0% closing prices, September 4, 2025 to September 8, 2026
- 5-year change
- -99.9% closing prices, September 8, 2021 to September 8, 2026
Company Description
HERO TECHNOLOGIES (OTC: HENC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $55.3K.
HENC has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2022, HERO TECHNOLOGIES reported revenue of $0 with net income of -$542K.
This page collects what Stock Titan holds for HENC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HERO TECHNOLOGIES (HENC) closed at $0.0001 on September 8, 2026. Over the past 12 months, the price has gained 0.0%.
HENC Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
HERO TECHNOLOGIES has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. View all HENC news →
SEC Filings
Financial Highlights
net income was -$542K. The company generated -$185K in operating cash flow. With a current ratio of 0.05, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
HENC Company Profile & Sector Positioning
HERO TECHNOLOGIES (HENC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HENC often look at related companies in the same sector, including OWC PHARMS RESEARCH CORP (OWCP), CANNONAU CORP (CNNC), WSTN SIERRA RESOURCE CRP (WSRC), EMERGENT HEALTH CORP (EMGE), and RISING BIOSCIENCES INC (RBII). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HENC's relative position within its industry.